Skip to content

SMARTLOAD GCB00 (REF GCB0000310)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · SMARTLOAD TECNIS 1PC CLEAR MONO 31.0D · Class 3

All models of SMARTLOAD (52)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474620827), received between Jul 9, 2021 and Jul 9, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Fragmentation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Material Fragmentation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 9, 2021Material Fragmentation; Material Fragmentation

    IT WAS REPORTED THAT THE CUSTOMER SENT IN A FAX INDICATING LENS AS DEFECTIVE. NO FURTHER DETAILS WERE GIVEN. CUSTOMER SERVICE CALLED THE CUSTOMER ABOUT IT. THEY CONFIRMED THE IMPLANTATION AND EVENT DATE AS (B)(6) 2021. FOR GCB0000310 THEY REPORTED THE DEFECT AS ONE HAPTIC MISSING, THIS WAS NOTICED UPON OPENING THE PACKAGING. THEY WARE UNAWARE ABOUT THE NATURE OF THE DEFECT OF GCB0000300. THE SURGERY WAS COMPLETED WITH GCB0000305 SN (B)(4). THEY REPORTED NO ISSUES REGARDING THE PATIENT. BOTH LENSES WERE DESTROYED. NO OTHER INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12145616 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page